New! Sign up for our free email newsletter.

Skin Cancer News

April 30, 2025

Top Headlines

 

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as skin, lung, or bone and soft tissue cancer ...
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...
Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL ...
A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ...

Latest Headlines

updated 2:43pm EDT

Earlier Headlines

 

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor environment. The results ...

Scientists developed a way of using artificial intelligence to check for skin cancer with the AI tool, which was trained on data from 53,601 skin lesions from 25,105 patients, outperforming existing ...

Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study unexpectedly finds that estrogens play a role in fueling the growth of breast cancers ...

Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or ...

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is ...

A study analyzing long-term melanoma data reveals important insights into melanoma incidence trends in men and ...

The risk of skin cancer for adults under the age of 50 is now decreasing for the first time in ...

Age-related changes in the fibroblasts, cells that create the skin's structure, contribute to the development of aggressive, treatment-resistant melanoma in males, according to new ...

A new tool for monitoring immune health patterns over time reveals how a pair of checkpoint inhibitor therapies works together to recruit new cancer-fighting T cells with every ...

Scientists provide a comprehensive overview of the evolution and potential of TIL therapy. They describe its development and highlight its transformative ...

In many cases of malignant melanoma, the effect of targeted treatment is lost over time. A research team has now discovered that a factor secreted by tumor cells is responsible for the resistance. ...

An international research team has discovered a new way to effectively treat cancer, by using nutrients to reactivate suppressed metabolic pathways in cancer ...

Scientists have discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies. Inhibition of the VARS enzyme could prevent this therapeutic resistance ...

A new study shows that genetics play a larger role in melanoma risk than recognized. Researchers report that up to 15% (1 in 7) of patients who received melanoma diagnoses from Cleveland Clinic ...

An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study. The treatment, composed of nanoparticles fashioned ...

Melanoma, an aggressive form of skin cancer that accounts for 75% of all skin-cancer-related deaths, is often detected later in people with darker skin complexions -- and the consequences can be ...

Recent reproductive research has opened the door for new treatments for solid cancer tumors, including breast cancer, lung cancer and ...

A new study has revealed an association between favorable survival outcomes for melanoma patients and the presence of higher populations of tissue-resident memory T cells (TRM). Data obtained from ...

New research explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient's T cells outside the body before ...

Thursday, March 13, 2025

Tuesday, November 19, 2024

Thursday, October 17, 2024

Friday, September 27, 2024

Monday, September 16, 2024

Friday, September 13, 2024

Thursday, September 12, 2024

Monday, September 9, 2024

Friday, September 6, 2024

Thursday, August 29, 2024

Thursday, July 18, 2024

Thursday, June 27, 2024

Tuesday, June 18, 2024

Friday, June 7, 2024

Thursday, May 23, 2024

Monday, May 13, 2024

Friday, May 10, 2024

Tuesday, May 7, 2024

Thursday, May 2, 2024

Tuesday, April 16, 2024

Wednesday, March 20, 2024

Wednesday, December 13, 2023

Wednesday, November 29, 2023

Tuesday, November 28, 2023

Friday, October 27, 2023

Tuesday, September 5, 2023

Thursday, August 31, 2023

Thursday, August 10, 2023

Thursday, July 27, 2023

Wednesday, July 26, 2023

Wednesday, July 5, 2023

Monday, June 26, 2023

Friday, June 23, 2023

Wednesday, May 31, 2023

Thursday, March 30, 2023

Tuesday, March 28, 2023

Thursday, February 16, 2023

Monday, January 23, 2023

Monday, January 9, 2023

Wednesday, December 21, 2022

Friday, December 16, 2022

Wednesday, December 7, 2022

Monday, November 28, 2022

Monday, October 31, 2022

Wednesday, September 28, 2022

Thursday, September 22, 2022

Tuesday, September 20, 2022

Monday, September 19, 2022

Thursday, September 1, 2022

Tuesday, August 23, 2022

Monday, August 15, 2022

Wednesday, August 3, 2022

Wednesday, July 20, 2022

Friday, July 15, 2022

Thursday, July 14, 2022

Thursday, June 23, 2022

Tuesday, June 21, 2022

Wednesday, June 15, 2022

Thursday, June 9, 2022

Wednesday, June 1, 2022

Tuesday, May 31, 2022

Monday, May 9, 2022